Effect of Momordica charantia and Ocimum basilicum on KRAS expression in AOM-induced colon cancer in rats
Main Article Content
Abstract
Abstract. Okelola CA, Odufuwa KT, Ezima EN, Adegbesan BO, Bello TH. 2025. Effect of Momordica charantia and Ocimum basilicum on KRAS expression in aom-induced colon cancer in rats. Asian J Nat Prod Biochem 23: 93-100. KRAS is one of the most frequently mutated oncogenes in colorectal cancer (CRC), contributing to tumor progression and therapeutic resistance. In light of increasing interest in phytotherapy, this study investigated the modulatory effects of aqueous extracts of Momordica charantia and Ocimum basilicum on KRAS gene expression in azoxymethane (AOM)-induced colon cancer in rats. Forty adult male Wistar rats were randomly assigned into five groups (n = 8 per group): three treatment groups (receiving 50, 100, and 200 mg/kg/day of the extract), an AOM-only negative control, and a distilled water-treated normal control. AOM was administered at 20 mg/kg/week for four weeks to induce colon carcinogenesis. After treatment, colon tissues were harvested for histological examination and KRAS gene expression analysis using quantitative real-time PCR (qRT-PCR). Phytochemical screening confirmed the presence of alkaloids, flavonoids, saponins, and phenols in the extracts. Histological evaluation revealed dose-dependent protection in extract-treated groups, with restoration of mucosal structure and reduced atypical features. qRT-PCR showed significant downregulation of KRAS gene expression in the high-dose group (200 mg/kg), with a 2.8-fold reduction compared to the AOM-only group (p < 0.01). The medium-dose group showed a moderate 1.6-fold reduction, while the low-dose group exhibited slight upregulation of KRAS expression. These findings suggest that aqueous extracts of M. charantia and O. basilicum exert chemopreventive effects in AOM-induced colon cancer, likely through phytochemical-mediated downregulation of oncogenic KRAS expression and preservation of colon histoarchitecture. The study supports the potential use of these plants as complementary agents in colorectal cancer therapy.
Article Details
Issue
Section
References
Ahmad, N., Hasan, N., Ahmad, Z., Zishan, M., and Zohrameena, S. 2016. Momordica Charantia: For Traditional Uses and Pharmacological Actions. Journal of Drug Delivery and Therapeutics, 6(2), 40-44.
AOAC, 2015. Official Methods of Analysis. Association of Official Analytical Chemists, Washington, DC, USA, 14th edition.
Arthur, F.K.N., Woode, E., Terlabi, E.O and Larbie, C. 2011. Evaluation of acute and subchlornic toxicity of Annona muricata (Linn.) aqueous extract in animals. European Journal of Experimental Biology. 1(4): 115-124.
Canon, J., Rex, K., Saiki, A. Y., Mohr, C., Cooke, K., Bagal, D., and Lipford, J. R. 2019. The clinical KRAS (G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature, 575(7781), 217–223.
Eftekhar, N., Moghimi, A., Mohammadian Roshan, N., Saadat, S., and Boskabady, M.H. 2019. Immunomodulatory and anti-inflammatory effects of hydro-ethanolic extract of Ocimum basilicum leaves and its effect on lung pathological changes in an ovalbumin-induced rat model of asthma. BMC Complement. Altern. Med. 19, 349.
Ejikeme, C. M., Ezeonu, C. S and Eboatu, A. N 2014. “Determination of physical and phytochemicalconstituents of some tropical timbers indigenous to Niger Delta Area of Nigeria,” European Scientific Journal. 10 (18):247–270.
Islam, M. R., Akash, S., Rahman, M. M., Nowrin, F. T., Akter, T., Shohag, S. and Simal-Gandara, J. 2022. Colon cancer and colorectal cancer: Prevention and treatment by potential natural products. Chemico- biological interactions, 368, 110170.
La Torre, V. E, Guarniz, W. S., Silva-Correa, C., Razco, L. C., and Siche, R. 2020. Antimicrobial Activity and Chemical Composition of Momordica Charantia: A Review. Pharmacognosy Journal. 12(1):213-222.
Li, C., Lau, H. C.-H., Zhang, X., and Yu, J. (2022). Mouse Models for Application in Colorectal Cancer: Understanding the Pathogenesis and Relevance to the Human Condition. Biomedicines, 10(7), 1710. https://doi.org/10.3390/biomedicines10071710
Liu, C., Sun, J., Lu, Y., Bo, Y., and Song, Y. (2019). Ocimum basilicum extract inhibits proliferation and induces apoptosis in colorectal cancer cells. Biomedicine & Pharmacotherapy, 112, 108600.
Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2^ (-??Ct) method. Methods, 25(4), 402–408.
Raina, R., Soni, R., Dogra, R., Kaul, S., Choudhary, S., and Verma, P. K. 2020. Chemopreventive and anticancer potential of Momordica charantia: A mini review. Journal of Cancer Research and Therapeutics, 16(3), 471–476.
Ryan, M. B., and Corcoran, R. B. 2018. Therapeutic strategies to target RAS-mutant cancers. Nature Reviews Clinical Oncology, 15(11), 709–720.
Shenoy, S., Anitha, T., and Rajesh, B. 2016. Antioxidant and antiproliferative activities of Ocimum basilicum extracts on colon cancer cells. Pharmacognosy Journal, 8(6), 579– 584.
Singh, D., Goel, A., Singh, R. P., and Dey, A. 2022. Medicinal significance of bioactive compounds in Ocimum and Momordica species against human cancers. Frontiers in Pharmacology, 13, 925436.
Skoulidis, F., and Heymach, J. V. 2019. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy. Nature Reviews Cancer, 19(9), 495–509.
Sparg, S. G., Light, M. E., & van Staden, J. 2004. Biological activities and distribution of plant saponins. Journal of Ethnopharmacology, 94(2-3), 219–243.
Vimala, J.R., Leema, R.A., Raja, S 2012. A study on the phytochemical analysis and corrosion inhibition on mild steel by Annona muricata L. leaves extract in 1N hydrochloric acid. Der Chemica Sinica. 3(3): 582–588.
Wink, M. 2020. Functions and biotechnology of plant secondary metabolites. Annual Plant Reviews, 39(2), 145– 170.
Zhang, L., Ravipati, A. S., Koyyalamudi, S. R., Jeong, S. C., Reddy, N., Bartlett, J., and Smith, P. T. (2018). Antioxidant and anti-inflammatory activities of tannins. Phytotherapy Research, 32(3), 444–458.